Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322414/
https://www.ncbi.nlm.nih.gov/pubmed/37416284
http://dx.doi.org/10.1155/2023/9870685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322414/
https://www.ncbi.nlm.nih.gov/pubmed/37416284
http://dx.doi.org/10.1155/2023/9870685

Ejemplares similares